MMP9 and Cerebral ischemia: The iron chelator deferoxamine was shown to reduce mitochondrial oxidative stress in a transient cerebral ischemia model as well as the release of pro-inflammatory molecules including matrix metalloproteinase-9 and hypoxia inducible factor-1 (Im et al., 2012).